People · Operator
Named in public records as an officer, director or promoter · active 2017–2017 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Acura Pharmaceuticals, Inc | — | Pharmaceuticals | Seed | $4.0M | $152.2M | 2017 |
James F. Emigh at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James F. Emigh on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Peter A. Clemens | 1 | 16 |
| Albert W. Brzeczko | 1 | 1 |
| George K. Ross | 1 | 1 |
| Bruce K. Wesson | 1 | 1 |
| Immanuel K. Thangaraj | 1 | 1 |
| Robert B. Jones | 1 | 1 |
| Robert W. Seiser | 1 | 1 |
| William B. Skelly | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.